Brown, who was vice president of cardiovascular research for Boston Scientific for the past decade, has logged 24 years in the medical device industry, according to a press release. His career began with SciMed Life Systems, which Boston acquired in 1994, according to the release.
Sunshine Heart makes the C-Pulse heart assist system, an outside-the-bloodstream left ventricular assist device that helps circulate blood and reduce the pumping burden on a patient’s heart. The device won CE Mark approval in the European Union and conditional FDA approval in 2012.
"Brian brings a broad range of experiences covering all aspects of transforming new technologies into marketable products. His specific role in leading the technology transition from an early stage development company to one of the largest cardiovascular device corporations in the world is extremely valuable to an emerging company such as Sunshine Heart," Sunshine Heart CEO Dave Rosa said in prepared remarks.
InVivo Therapeutics makes interim CFO McAllister its permanent finance chief
InVivo Therapeutics (OTC:NVIV)
said it made interim CFO Steven McAllister, a Biomet veteran, as its permanent finance chief.
Repro-Med Systems shuffles the deck
Repro-Med Systems (OTC:REPR) shuffled the deck earlier this month, adding Baxter (NYSE:BAX) veteran Rick McWhorter as interim COO and promoting administration director Barry Short to the interim CFO role.
RIP Greatbatch, Analogic director Melia
Kevin Melia, a member of the board of directors at Greatbatch (NYSE:GB) and Analogic (NSDQ:ALOG), died last week after a brief illness. Melia was also a director at RadiSys Corporation, DCC plc, Manugistics Corp. and Eircom Inc.
"Kevin was a trusted friend and colleague. His wit and his wisdom were treasured by all of us. He will be truly missed," Analogic chairman Ed Voboril said in prepared remarks.
"Kevin’s contribution to our Board has been immeasurable. Since joining our Board in 2009, he has provided invaluable guidance to me and our senior management team. He was a good and valued friend. Our thoughts and prayers go out to his family, and we will miss him," added president & CEO Jim Green.
"Kevin was a highly regarded and well respected leader since joining the Greatbatch Board of Directors in 2007. His wisdom and insights were a guiding force as Greatbatch embarked on new strategies and technologies that would ultimately have a positive impact on the lives of countless patients worldwide," Greatbatch said in a prepared statement. "More important than his professional accomplishments, however, was his love and dedication to his wife Ann and their family. Our hearts and thoughts go out to the Melia family as they deal with the devastating loss of this great man. Kevin will be missed by us all."
"We mourn the passing of Glenn, both as a fellow board member and a friend," chairman & CEO George Barrett said in prepared remarks. "Glenn was a leader in his industry and brought deep wisdom to our board. A man of tremendous accomplishments, Glenn always demonstrated humility and a deep interest in others. He leaves a lasting legacy and will be missed by all of us."